Joyce O'Shaughnessy, Julie Marie Collins, Lili Yao, Karen L. Smith, Jaime A. Mejia, Michael A. Danso. "HERTHENA-Breast03: A phase 2, randomized, open-label study evaluating neoadjuvant patritumab deruxtecan + pembrolizumab before or after pembrolizumab + chemotherapy for early-stage TNBC or HR-low+/HER2− breast cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps629